Relay Therapeutics Inc (RLAY)
Healthcare
Biotechnology
18.80 $
-3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Relay Therapeutics Inc (RLAY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -235 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -44 | -66 | -102 | -74 | -229 | -300 | -249 | -235 | |
| 2.2 | 2.8 | 3.5 | 3.9 | 4.1 | 5.3 | 5.5 | -1.4 | |
| 2.9 | 4.5 | 32 | 48 | 56 | 86 | 94 | 62 | |
| 2.9 | 2.0 | 32 | 51 | 56 | – | – | – | |
| -0.4 | 4.3 | -85 | 97 | 11 | -32 | 15 | -23 | |
| 1.7 | 8.0 | 1.9 | 3.5 | 9.1 | 4.1 | 2.0 | 0.4 | |
| -1.7 | -319 | 82 | -480 | -189 | 258 | -41 | 193 | |
| -0.1 | 5.6 | 429 | 5.9 | 1.7 | – | 1.5 | 1.1 | |
| – | – | -2.5 | – | – | – | – | – | |
| 395 | 5.6 | 427 | 388 | 290 | 35 | 270 | 1.6 | |
| 349 | -380 | 406 | -166 | -128 | -7.9 | -20 | -41 | |
| -46 | -74 | -104 | -78 | -239 | -304 | -251 | -236 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.